Section 1 | Section 2 | Section 3
Section 1
Contact William
Document 1 - 03/15/2012 - MT4554A
Medicines Authority Circular No P06/2012 Re: European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines- 20.02.2012
Medicines Authority Circular No P05/2012 Re: European Medicines Agency recommends lifting of the suspension of aprotinin- 20.02.Ô
Medicines Authority Circular No P04/2012 Re: European Medicines Agency reviews dose recommendations for anti-tuberculosis medicines used in children- 20.02.2012
Medicines Authority Circular No P03/2012 Re: European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines - 20.02.2012